Cost-effectiveness of rituximab (MabThera®) in diffuse large B-cell lymphoma in the Netherlands
M. T. Groot, P. J. Lugtenburg, J. Hornberger, P. C. Huijgens, C. A. Uyl-de GrootVolume:
74
Year:
2005
Language:
english
Pages:
9
DOI:
10.1111/j.1600-0609.2004.00368.x
File:
PDF, 202 KB
english, 2005